Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3271836 | 1.00 | ALDH1A1 (0.41) | ALDH1A1ALOX15 | |
| SCHEMBL3271833 | 1.00 | ALDH1A1 (0.41) | ALDH1A1ALOX15 | |
| SCHEMBL11050564 | 0.98 | — | — | |
| SCHEMBL7171712 | 0.84 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL7171718 | 0.84 | ALDH1A1 (0.38) | ALDH1A1ALOX15 | |
| SCHEMBL42869 | 0.83 | — | — | |
| SCHEMBL16136558 | 0.83 | — | — | |
| SCHEMBL1230434 | 0.81 | ALDH1A1 (0.39) | ALDH1A1ALOX15 | |
| SCHEMBL1230432 | 0.81 | ALDH1A1 (0.39) | ALDH1A1ALOX15 | |
| SCHEMBL17656204 | 0.76 | ADH1A (0.32) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391597-B1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| EP-2391596-B1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2018-06-20 | — | — | EP | disclosed |
| US-8212082-B2 | Process for the isolation of dodecatrienal and its use as aroma substance | BASF SE (DE) | 2012-07-03 | — | — | US | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| EP-2391597-A1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086314-A1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2010-08-05 | — | — | WO | disclosed |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| EP-2041059-B1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2010-06-16 | — | — | EP | disclosed |
| EP-2041060-B1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-12-16 | — | — | EP | disclosed |
| EP-2041059-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-04-01 | — | — | EP | disclosed |
| EP-2041060-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF SE (DE) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008000756-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-03 | — | — | WO | disclosed |
| WO-2008000757-A1 | METHOD FOR THE PRODUCTION OF CYCLIC KETONES | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | ALDH1A1 503/4885ALOX15 142/4885 |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | CCNA1, OXER1, CCNA2 | ALDH1A1 80/4885ALOX15 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.